… hematoma occurring secondary to the use of Apixaban. The patient was an 80 year old …
Evaluation of his course revealed the use of a Factor Xa inhibitor, namely Apixaban, for new …

… A new class of anticoagulant drugs is available, which includes the oral direct Factor Xa
inhibitors rivaroxaban, apixaban… showed that apixaban caused reversible Factor Xa inhibition in …

… use of anti-Xa DOACs (apixaban, … anti-Xa activity have created new challenges with
managing heparin infusions.The heparin anti-Xa assay is highly sensitive to the factor Xa inhibitors …

… New oral anticoagulants (NOACs) have become more popular in the last few decades. …
as coagulation factor Xa) reverses factor Xa inhibition by acting as a decoy factor Xa with no …

… apixaban dose administration. Secondary outcomes included new VTE while on apixaban,
… regimen adjustments, and factor Xa inhibitor-specific anti-Xa levels if available. A total of 68 …

… inhibitors or Factor Xa inhibitors, which include apixaban. These type of inhibitors act by
reversibly blocking Factor Xa … major downside to these new anticoagulants is that they cannot be …

… Factor Xa Inhibitors have emerged as a first-line agent in the management of non-valvular …
cohort study comparing the use of Factor Xa Inhibitors (apixaban and rivaroxaban) to warfarin …

… -factor prothrombin complex concentrate (4F-PCC) as an antidote for major bleeding events
due to apixaban … the two agents in patients with oral factor Xa inhibitor related traumatic and …

… and prothrombinase activity, and clot-bound factor Xa activity. It … The first antidote to
factor Xa inhibitors, apixaban and … To date, the antidote to factor Xa inhibitors has not been …

… assessing the factor Xa inhibitors apixaban, rivaroxaban and edoxaban are essential to the
new guidelines.7., 8., 9., 10. In these trials, patients were treated with a factor Xa inhibitor for …